Jack Leslie

Dr. Jack Leslie is a researcher at Newcastle University specializing in hepatocellular carcinoma (HCC), liver fibrosis, and immunotherapy. His work spans lipid metabolism, neutrophil biology, and precision medicine approaches to liver disease.

• Research Interests: Hepatocellular carcinoma, liver fibrosis, neutrophil-mediated immunotherapy, lipidomics, metabolic remodeling, and precision medicine.
• Article Trends: Recent work focuses on spatial lipidomics for fibrosis targets, CXCR2 inhibition in NASH-HCC immunotherapy, neutrophil roles in tumor microenvironments, and metabolic pathways like mTOR-Plin3 in liver health.
• Collaborators/Students: Amy Collins, Erik Ramon Gil, Daniel Geh, Zosia Johnson, Jeremy French, Saimir Luli, and Jill Hunter.
• Labs/Teams: Collaborates on bioreactor technology for liver fibrosis modeling and near-infrared imaging techniques for inflammatory response monitoring.